Filing Details

Accession Number:
0001401708-17-000092
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-15 17:08:34
Reporting Period:
2017-11-13
Accepted Time:
2017-11-15 17:08:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401708 Nanostring Technologies Inc NSTG Biological Products, (No Disgnostic Substances) (2836) 200094687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1592508 W. David Ghesquiere 530 Fairview Avenue N
Seattle WA 98109
Svp, Corporate & Business Dev No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-13 2,500 $0.00 17,327 No 4 M Direct
Common Stock Disposition 2017-11-13 689 $8.14 16,638 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2017-11-13 2,500 $0.00 2,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 No 5 M Direct
Footnotes
  1. The sale reported on this Form 4 was effected pursuant to a non-discretionary, Issuer-mandated sell-to-cover arrangement, in order to cover tax withholding incident to the automatic acquisition of the vested portion of the restricted stock units ("RSUs") on the transaction date.
  2. Each RSU represents a contingent right to receive one (1) share of Issuer's common stock.
  3. On November 10, 2016, the reporting person was granted 7,500 RSUs vesting in three equal installments beginning on the first market trading day following the first anniversary of the grant date.